All News

Dietary interventions that raise levels of high-density lipoprotein, or good cholesterol, may affect fatigue symptoms in multiple sclerosis.

An autopsy-based study examined long-term trends in HIV-related mortality among individuals living with the disease in New York City.

Hurtado Health Center, Busch-Livingston Health Center, and Cook Douglass Health Center will be closing after over a year of discussion, mainly due to budget constraints and a decline in use by the students in most recent years.

The FDA has issued a warrning letter to JUUL Labs Inc. regarding marketing and advertising practices.

What caused this man to permanently lose his sense of smell?

Results from a phase 2 study demonstrated complete tumor responses in patients with metastatic renal cell carcinoma treated with the combination lixadencel and sunitinib.

Novel combination may improve efficacy of immune checkpoint inhibitors in treating non-small cell lung cancer.

Misinformation associated with the antivaccination movement has been a driving force contributing to the increase in vaccine preventable diseases, especially amidst the global measles outbreak.

Caring for patients in a rural community is vastly different than in a city, and students at 2 universities got a chance to see the differences firsthand earlier this year.

SGLT2 inhibitors are indicated to reduce blood glucose by causing the kidneys to remove sugar from the body through the urine.

Johns Hopkins Medical has announced a new Center for Psychedelic and Consciousness Research, funded with $17 million from private donors.

Nintedanib (Ofev, Boehringer Ingelheim) is now the first therapy approved for patients with interstitial lung disease associated with systemic sclerosis.

Positive Phase III study results have shown that preventive flu treatment with baloxavir marboxil after exposure to an infected household member reduced the risk of contraction by 86% versus a placebo, according to Roche.

There are currently no FDA-approved targeted therapies to treat metastatic MET exon14 skipping-mutated non-small cell lung cancer (NSCLC), according to the Novartis.

Two separate studies highlighted how high drug costs and requirements for prior authorization can hinder access to cancer treatment and affect outcomes.

Anifrolumab (AstraZeneca) demonstrated a statistically significant and clinically meaningful reduction in disease activity based on composite lupus assessment.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

The Phase III ETHOS trial for AstraZeneca's budesonide, glycopyrronium and formoterol fumarate, 320/14.4/9.6mcg (Breztri Aerosphere) combination therapy has demonstrated positive results for patients with moderate to severe chronic obstructive pulmonary disease (COPD).

Pharmacists can assist with advising patients who present with quality concerns to use CBD products that provide certificates of analyses, and catch significant drug interactions before they occur.

Voxelotor (Global Blood Therapeutics) is being developed for patients with sickle cell disease.

Oncologists suggest that substituting nab-paclitaxel instead of paclitaxel prior to surgery may lead to reduced risk of disease recurrence for certain women with breast cancer.

Top news of the day from across the health care landscape.

Researchers at Weill Cornell Medicine have found that states requiring prescribers and dispensers to register with and use prescription drug monitoring programs saw significantly fewer opioid prescriptions and reduced opioid-related hospital use, when compared to states with weak drug monitoring program mandates.

These funds are earmarked for the expansion of access to treatment and to support near real-time data on drug overdoses.

A federal court has ordered 2 Tennessee-based companies with the same owner to stop disstributing drugs, dietary supplements, and devices until they are found to be in compliance with the Federal Food, Drug, and Cosmetic (FD&C) Act and other requirements.

Health system specialty pharmacies are creating a more integrated care structure for complex patients on specialty drug regimens.

Building on the current understanding of spihingosine 1-phosphate levels in regulating T cell function, researchers found that the inhibition of the lipid can lead to more effective uses of immunotherapy in cancer therapy.